FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to 5-(4-hydroxyphenyl)- and 5-(2,5-dihydroxyphenyl)-6H-1,3,4-thiadiazine-2-amines, hydrohalogenides of general formulas and inhibiting thrombocyte aggregation in the intravenous introduction NR1R1-morpholino-; thiomorpholino-; pyrrolidino-; piperidino-; hexamethyleneimino-, HHal - HCl; HBr.
EFFECT: given compounds may be used for preparing cardiologic drugs and enable better treatment of various cardiovascular diseases, including myocardial infarction and thrombotic apoplexy.